558 related articles for article (PubMed ID: 32613204)
1. Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling.
Corsello SM; Nagari RT; Spangler RD; Rossen J; Kocak M; Bryan JG; Humeidi R; Peck D; Wu X; Tang AA; Wang VM; Bender SA; Lemire E; Narayan R; Montgomery P; Ben-David U; Garvie CW; Chen Y; Rees MG; Lyons NJ; McFarland JM; Wong BT; Wang L; Dumont N; O'Hearn PJ; Stefan E; Doench JG; Harrington CN; Greulich H; Meyerson M; Vazquez F; Subramanian A; Roth JA; Bittker JA; Boehm JS; Mader CC; Tsherniak A; Golub TR
Nat Cancer; 2020 Feb; 1(2):235-248. PubMed ID: 32613204
[TBL] [Abstract][Full Text] [Related]
2. Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.
Islam S; Wang S; Bowden N; Martin J; Head R
Br J Clin Pharmacol; 2022 Jan; 88(1):64-74. PubMed ID: 34192364
[TBL] [Abstract][Full Text] [Related]
3. Repurposing disulfiram to target infections caused by non-tuberculous mycobacteria.
Das S; Garg T; Chopra S; Dasgupta A
J Antimicrob Chemother; 2019 May; 74(5):1317-1322. PubMed ID: 30753528
[TBL] [Abstract][Full Text] [Related]
4. PDE3A inhibitor anagrelide activates death signaling pathway genes and synergizes with cell death-inducing cytokines to selectively inhibit cancer cell growth.
An R; Liu J; He J; Wang F; Zhang Q; Yu Q
Am J Cancer Res; 2019; 9(9):1905-1921. PubMed ID: 31598394
[TBL] [Abstract][Full Text] [Related]
5. Concurrent oral delivery of non-oncology drugs through solid self-emulsifying system for repurposing in hepatocellular carcinoma.
Ardad RM; Manjappa AS; Dhawale SC; Kumbhar PS; Pore YV
Drug Dev Ind Pharm; 2023 Dec; 49(5):377-391. PubMed ID: 37216496
[TBL] [Abstract][Full Text] [Related]
6. Cancer Pro-oxidant Therapy Through Copper Redox Cycling:
Rieber M
Curr Pharm Des; 2020; 26(35):4461-4466. PubMed ID: 32600223
[TBL] [Abstract][Full Text] [Related]
7. Drug Repurposing as an Antitumor Agent: Disulfiram-Mediated Carbonic Anhydrase 12 and Anion Exchanger 2 Modulation to Inhibit Cancer Cell Migration.
Hwang S; Shin DM; Hong JH
Molecules; 2019 Sep; 24(18):. PubMed ID: 31546841
[TBL] [Abstract][Full Text] [Related]
8. Validation of transcriptome signature reversion for drug repurposing in oncology.
Koudijs KKM; Böhringer S; Guchelaar HJ
Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36445193
[TBL] [Abstract][Full Text] [Related]
9. Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent.
Shirley DA; Sharma I; Warren CA; Moonah S
Front Cell Infect Microbiol; 2021; 11():633194. PubMed ID: 33777846
[TBL] [Abstract][Full Text] [Related]
10. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
[TBL] [Abstract][Full Text] [Related]
11. Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents.
Ekinci E; Rohondia S; Khan R; Dou QP
Recent Pat Anticancer Drug Discov; 2019; 14(2):113-132. PubMed ID: 31084595
[TBL] [Abstract][Full Text] [Related]
12. Repurposing Disulfiram as a Chemo-Therapeutic Sensitizer: Molecular Targets and Mechanisms.
Sun F; Wang H; Nie J; Hong B
Anticancer Agents Med Chem; 2022; 22(17):2920-2926. PubMed ID: 35430981
[TBL] [Abstract][Full Text] [Related]
13. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4.
Skrott Z; Mistrik M; Andersen KK; Friis S; Majera D; Gursky J; Ozdian T; Bartkova J; Turi Z; Moudry P; Kraus M; Michalova M; Vaclavkova J; Dzubak P; Vrobel I; Pouckova P; Sedlacek J; Miklovicova A; Kutt A; Li J; Mattova J; Driessen C; Dou QP; Olsen J; Hajduch M; Cvek B; Deshaies RJ; Bartek J
Nature; 2017 Dec; 552(7684):194-199. PubMed ID: 29211715
[TBL] [Abstract][Full Text] [Related]
14. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
Banerjee P; Geng T; Mahanty A; Li T; Zong L; Wang B
Int J Pharm; 2019 Feb; 557():374-389. PubMed ID: 30610896
[TBL] [Abstract][Full Text] [Related]
15. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
Sun T; Yang W; Toprani SM; Guo W; He L; DeLeo AB; Ferrone S; Zhang G; Wang E; Lin Z; Hu P; Wang X
Cell Commun Signal; 2020 Mar; 18(1):36. PubMed ID: 32138738
[TBL] [Abstract][Full Text] [Related]
16. Repurposing some of the Well-known Non-steroid Anti-inflammatory Drugs (NSAIDs) for Cancer Treatment.
Sousa SM; Xavier CPR; Vasconcelos MH; Palmeira A
Curr Top Med Chem; 2023; 23(13):1171-1195. PubMed ID: 36717997
[TBL] [Abstract][Full Text] [Related]
17. Integrating LINCS Data to Evaluate Cancer Transcriptome Modifying Potential of Small-molecule Compounds for Drug Repositioning.
Zhao Y; Liu Y; Bai H
Comb Chem High Throughput Screen; 2021; 24(9):1340-1350. PubMed ID: 33109034
[TBL] [Abstract][Full Text] [Related]
18. Drugs Repurposing in High-Grade Serous Ovarian Cancer.
Torralba M; Farra R; Maddaloni M; Grassi M; Dapas B; Grassi G
Curr Med Chem; 2020; 27(42):7222-7233. PubMed ID: 32660396
[TBL] [Abstract][Full Text] [Related]
19. The anti-alcohol dependency drug disulfiram inhibits the viability and progression of gastric cancer cells by regulating the Wnt and NF-κB pathways.
Zhang J; Pu K; Bai S; Peng Y; Li F; Ji R; Guo Q; Sun W; Wang Y
J Int Med Res; 2020 Jun; 48(6):300060520925996. PubMed ID: 32529870
[TBL] [Abstract][Full Text] [Related]
20. Overcoming cancer therapeutic bottleneck by drug repurposing.
Zhang Z; Zhou L; Xie N; Nice EC; Zhang T; Cui Y; Huang C
Signal Transduct Target Ther; 2020 Jul; 5(1):113. PubMed ID: 32616710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
